Value
7.9/10data confidence 67%| Component | Sub-score |
|---|---|
| P/E | 8.7 |
| P/S | 3.8 |
| EV/EBITDA | 6.2 |
| Analyst target | 9.0 |
- ▸Attractively valued
APMD · Why this verdict
Why Apnimed (APMD) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score6.1/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Apnimed screens with strong financial-strength characteristics and net insider buying, and ranks as a growth leader among industry peers, with a value profile that skews constructive on price-to-earnings. No current share price is available this run, so no trade setup or risk/reward can be computed.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The company screens with strong financial strength, flagged explicitly via a high Piotroski F-Score reading in the quality assessment. Quality breakdown | The financial-strength signal should hold or improve, with the Piotroski-style read staying at the strong end of its scale. | →Stable |
| CounterA single financial-strength score can mask the fact that broader quality inputs, such as margin and growth notes, are largely absent from this assessment, so the strong read may not capture the full risk picture. | ||
Recent insider activity is net bullish, with two buy transactions and no sales, adding roughly 325,000 shares on a net basis. Insider transaction read | Insider buying should continue, or at least not reverse into net selling, over the following quarters. | →Stable |
| CounterThe insider read carries low confidence in the underlying assessment, and a single reporting period of buying is a thin sample from which to infer sustained insider conviction. | ||
The company ranks as an industry growth leader relative to peers, with the growth-rank component sitting at the top of its scale. Peer-rank breakdown | The company should maintain or extend its relative growth leadership position versus industry peers. | →Stable |
| CounterPeer-relative growth rank says nothing about absolute growth durability or path to profitability, and the growth dimension itself lacks supporting notes or data in this bundle, limiting confidence in the read. | ||
Valuation components are mixed but skew constructive, with the price-to-earnings read the strongest of the three inputs, EV/EBITDA moderately above average, and price-to-sales the softest of the group. Components | The price-to-sales component should improve from its current soft reading as the overall value picture firms up. | ↑Improving |
| CounterThe value assessment's confidence is only moderate, and without any accompanying notes to explain the scoring, the valuation read here is less reliable than for names with fuller data coverage. | ||
The company screens with strong financial strength, flagged explicitly via a high Piotroski F-Score reading in the quality assessment.
→StableQuality breakdown
- Expectation
- The financial-strength signal should hold or improve, with the Piotroski-style read staying at the strong end of its scale.
CounterA single financial-strength score can mask the fact that broader quality inputs, such as margin and growth notes, are largely absent from this assessment, so the strong read may not capture the full risk picture.
Recent insider activity is net bullish, with two buy transactions and no sales, adding roughly 325,000 shares on a net basis.
→StableInsider transaction read
- Expectation
- Insider buying should continue, or at least not reverse into net selling, over the following quarters.
CounterThe insider read carries low confidence in the underlying assessment, and a single reporting period of buying is a thin sample from which to infer sustained insider conviction.
The company ranks as an industry growth leader relative to peers, with the growth-rank component sitting at the top of its scale.
→StablePeer-rank breakdown
- Expectation
- The company should maintain or extend its relative growth leadership position versus industry peers.
CounterPeer-relative growth rank says nothing about absolute growth durability or path to profitability, and the growth dimension itself lacks supporting notes or data in this bundle, limiting confidence in the read.
Valuation components are mixed but skew constructive, with the price-to-earnings read the strongest of the three inputs, EV/EBITDA moderately above average, and price-to-sales the softest of the group.
↑ImprovingComponents
- Expectation
- The price-to-sales component should improve from its current soft reading as the overall value picture firms up.
CounterThe value assessment's confidence is only moderate, and without any accompanying notes to explain the scoring, the valuation read here is less reliable than for names with fuller data coverage.
Per-dimension breakdown
Quality
6.9/10data confidence 86%| Component | Sub-score |
|---|---|
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 0.0 |
| Current ratio | 6.7 |
| Moat | 7.0 |
| Piotroski F | 7.8 |
- ▸Strong Piotroski F-Score: 7/9
Growth
5.0/10data confidence 50%Momentum
3.7/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.5 |
| MACD | 0.6 |
| OBV | 10.0 |
| MA position | 3.5 |
| Volume | 0.8 |
- ▸Volume accumulation (rising OBV)
Sentiment
8.2/10data confidence 67%| Component | Sub-score |
|---|---|
| Analyst rating | 6.8 |
| Price target | 9.9 |
- ▸Light analyst coverage (3.0) — signal dampened
- ▸Analyst upside: 83%
Insider
8.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 8.0 |
| insider conviction | 8.0 |
- ▸Notable insider buying — $5,200,000 (0.455% of mkt cap)
Peer rank
6.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 6.4 |
| quality rank | 3.2 |
| growth rank | 10.0 |
- ▸Industry growth leader
Technical
6.0/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 6.2 |
| support resistance | 6.2 |
| 52w position | 5.6 |
| gap | 6.0 |
Risk (lower is worse)
0.0/10data confidence 20%| Component | Sub-score |
|---|---|
| volatility | 0.0 |
Catalyst
5.0/10data confidence 50%How the verdict was assembled
Engine trigger
Extreme risk factors.
Engine technical detail
verdict_path:
L1:HARD_BLOCK:RISK_FLOORPassed (7)
- ASYMMETRY:3.7>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:NO_DATE
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- MOMENTUM:3.7<4.5
Warning (0)
none
Reward-to-Risk
3.72
Upside
+55.9%
Downside
15.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeInst Constrain — Small cap ($1.1B) below institutional reach
SuitabilitySpeculative — Binary industry: Biotechnology
Investment implication
The SELL_IF_HOLDING verdict reflects the MOMENTUM gate's 3.7<4.5 outcome against Sentiment at 8.2 and asymmetric R:R of 3.72.
The strongest dimensions are Sentiment at 8.2, Insider at 8.0, and Value at 7.9; the weakest are Risk (lower is worse) at 0.0, Momentum at 3.7, and Catalyst at 5.0. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 3.72 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Strong Piotroski Financial Strength
Trip ifThe Piotroski F-Score reading drops to 4 out of 9 or below, down from the current 7 out of 9.
- P2Net Bullish Insider Buying
Trip ifNet insider selling exceeds 100,000 shares in a future reporting period, reversing the current net buying of roughly 325,000 shares.
- P3Industry Growth Leadership Rank
Trip ifThe growth-rank component falls below 5.0 on its 0-10 peer-relative scale, down from the current top-of-scale reading of 10.0.
- P4Constructive Pe Led Valuation
Trip ifThe price-to-earnings component score falls below 5.0 on its 0-10 scale, down from the current strong 9.4 reading.